2026 Brooklyn Lung Cancer Conference conference hero image

2026 Brooklyn Lung Cancer Conference

Accreditation: 8.50 Nursing Contact Hours | 8.50 ABIM MOC II | 8.50 ACPE Pharmacy | 8.50 AMA PRA Category 1 Credit™

Venue: New York Marriott at the Brooklyn Bridge, 333 Adams Street, NY, United States

Start Date: End Date:
Register for ConferenceCall for Abstract

Official conference page for 2026 Brooklyn Lung Cancer Conference.

About 2026 Brooklyn Lung Cancer Conference

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Stephanie Pan
52+

Faculty and committee

Our Speakers

Faculty

Nicholas Rohs

Nicholas Rohs, MD

Session Chair

Mount Sinai

Vamsi Velcheti

Vamsi Velcheti, MD

Session Chair

Balazs  Halmos

Balazs Halmos, MD

Topic Presenter

Montefiore Einstein Cancer Center

Sarah  Goldberg

Sarah Goldberg, MD, MPH

Topic Presenter

Yale University

Julia  Rotow

Julia Rotow, MD

Topic Presenter

Dana Farber Cancer Institute

Tina Cascone

Tina Cascone, MD, PhD

Topic Presenter

MD Anderson

Robert  Samstein

Robert Samstein, MD, PhD

Topic Presenter

Mount Sinai

Isabel Preeshagul

Isabel Preeshagul, DO

Topic Presenter

Memorial Sloan Kettering Cancer Center

Ashish Saxena

Ashish Saxena, MD, PhD

Topic Presenter

Weill Cornell Medicine

Grace Dy

Grace Dy, MD

Topic Presenter

Roswell Park Cancer Center

Shirish Gadgeel

Shirish Gadgeel, MBBS

Topic Presenter

Winship Cancer Institute of Emory University

Douglas Kondziolka

Douglas Kondziolka, MD

Topic Presenter

NYU Langone

Elaine Shum

Elaine Shum, MD

Topic Presenter

NYU Langone

Brendon Stiles

Brendon Stiles, MD

Topic Presenter

Montefiore Einstein Cancer Center

Olivia Fankuchen

Olivia Fankuchen, MD

Topic Presenter

Cornell University

Fionnuala Crowley

Fionnuala Crowley, MBBS

Topic Presenter

Mount Sinai

Christine Garcia

Christine Garcia, MD, MPH

Topic Presenter

Weill Cornell Medicine

Konstantin Dragnev

Konstantin Dragnev, MD

Topic Presenter

Dartmouth Cancer Center

Qian Wang

Qian Wang, MD

Topic Presenter

Case Western Reserve University

Ankeeta Joshi

Ankeeta Joshi

Topic Presenter

Sarah Waliany

Sarah Waliany, MD

Topic Presenter

Vincent  Lam

Vincent Lam, MD

Topic Presenter

Salman Punekar

Salman Punekar, MD

Topic Presenter

NYU Langone

Jamie Chaft

Jamie Chaft, MD

Topic Presenter

Memorial Sloan Kettering Cancer Center

Saumil Gandhi

Saumil Gandhi, MD, PhD

Topic Presenter

MD Anderson

Zoë Swainson

Zoë Swainson, MHA

Topic Presenter

Morana  Vojnic

Morana Vojnic, MD, MBA

Topic Presenter

Isabel Preeshagul

Isabel Preeshagul, DO

Faculty

Memorial Sloan Kettering Cancer Center

Fionnuala Crowley

Fionnuala Crowley, MBBS

Faculty

Mount Sinai

Grace Dy

Grace Dy, MD

Faculty

Roswell Park Cancer Center

Olivia Fankuchen

Olivia Fankuchen, MD

Faculty

Cornell University

Christine Garcia

Christine Garcia, MD, MPH

Faculty

Weill Cornell Medicine

Ashish Saxena

Ashish Saxena, MD, PhD

Faculty

Weill Cornell Medicine

Jamie Chaft

Jamie Chaft, MD

Faculty

Memorial Sloan Kettering Cancer Center

Nicholas Rohs

Nicholas Rohs, MD

Faculty

Mount Sinai

Elaine Shum

Elaine Shum, MD

Faculty

NYU Langone

Brendon Stiles

Brendon Stiles, MD

Faculty

Montefiore Einstein Cancer Center

Salman Punekar

Salman Punekar, MD

Faculty

NYU Langone

Shirish Gadgeel

Shirish Gadgeel, MBBS

Faculty

Winship Cancer Institute of Emory University

Benjamin  Herzberg

Benjamin Herzberg, MD

Faculty

Columbia University Medical Center

Konstantin Dragnev

Konstantin Dragnev, MD

Faculty

Dartmouth Cancer Center

Conference program and agenda

Our Agenda

Day 1: Saturday, August 8th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits
08:00 AM - 08:05 AMWelcome
08:05 AM - 09:05 AMSession 1: Targeted Therapy – EGFR (Salon H & I)

Session Chair: Joshua Sabari, MD

08:05 AM - 08:15 AM

EGFR-Mutant NSCLC: Sequencing Therapy After 1L Options Julia Rotow, MD

08:15 AM - 08:25 AM

Mechanisms of Resistance in EGFR-Mutant Lung Cancer: What Matters Clinically?

08:25 AM - 08:35 AM

Local Therapy in EGFR-Mutant NSCLC: Saumil Gandhi, MD, PhD

08:35 AM - 08:45 AM

Managing Toxicities of Modern Targeted Therapies: Practical Pearls Isabel Preeshagul, DO

08:45 AM - 09:05 AM

Case-Based Discussion

09:05 AM - 10:05 AMSession 2: Targeted Therapy – Other Mutations (Salon H & I)

Session Chair: Vamsi Velcheti, MD

09:05 AM - 09:15 AM

ALK-Positive NSCLC in 2026: Sequencing Beyond Lorlatinib Sarah Waliany, MD

09:15 AM - 09:25 AM

ROS1-Positive NSCLC: Resistance and Emerging Therapies Ashish Saxena, MD, PhD

09:25 AM - 09:35 AM

RET Fusion NSCLC: Current Standards and Future Directions Rajwanth Veluswamy, MD

09:35 AM - 09:45 AM

HER2-Mutant NSCLC: Where do ADCs fit? Balazs Halmos, MD

09:45 AM - 10:05 AM

Case-Based Discussion

10:05 AM - 10:30 AMBreak & Exhibits (Salon F & G) (Non - CME accredited)
10:30 AM - 11:30 AMSession 3: Targeted Therapy – KRAS (Salon H & I)

Session Chair: Rajwanth Veluswamy, MD

10:30 AM - 10:40 AM

Current Standards for KRAS G12C NSCLC: Where Are We Today? Grace Dy, MD

10:40 AM - 10:50 AM

The Path to Frontline KRAS Inhibition in NSCLC Shirish Gadgeel, MBBS

10:50 AM - 11:00 AM

Beyond G12C: Emerging Therapeutic Strategies for Non-G12C KRAS Mutations

11:00 AM - 11:10 AM

Mechanisms of Resistance and Future Directions in KRAS-Driven NSCLC Konstantin Dragnev, MD

11:10 AM - 11:30 AM

Case-Based Discussion

11:30 AM - 12:30 PMSession 4: CNS Metastases and High-Risk Disease in NSCLC (Salon H & I)

Session Chair: Nicholas Rohs, MD

11:30 AM - 11:40 AM

Managing Leptomeningeal Disease Morana Vojnic, MD, MBA

11:40 AM - 11:50 AM

ctDNA and Minimal Residual Disease in NSCLC: Identifying Patients at Highest Risk of Recurrence

11:50 AM - 12:00 PM

Immunotherapy for Untreated Brain Metastases: What Have We Learned? Sarah Goldberg, MD, MPH

12:00 PM - 12:10 PM

Gamma Knife Surgery in 2026: Pushing the Limits of Intracranial Disease Control Douglas Kondziolka, MD

12:10 PM - 12:30 PM

Case-Based Discussion

12:30 PM - 01:00 PMBinaytara's Efforts in Improving Cancer Care Disparities - Dr. Binay Shah (Non - CME accredited)
01:00 PM - 02:00 PMLunch, Posters & Product Theatre (Non - CME accredited)
02:00 PM - 03:00 PMSession 5: Early Stage Lung Cancer (Salon H & I)

Session Chair: Abraham Chachoua, MD

02:00 PM - 02:10 PM

Lung Cancer Screening in 2026: Who, When, and How? Elaine Shum, MD

02:10 PM - 02:20 PM

Perioperative Immunotherapy in Resectable NSCLC: What Is Standard in 2026? Jamie Chaft, MD

02:30 PM - 02:40 PM

Surgical vs Radiation Decision-Making in the Modern Era Brendon Stiles, MD

02:40 PM - 03:00 PM

Case-Based Discussion

02:20 PM - 02:30 PMResponse-Adapted Therapy and the Future of Curative-Intent Treatment
03:00 PM - 04:00 PMResearch Award (Salon H & I) (Non - CME accredited)

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship